Beam Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $14,269 | $11,772 | $7,410 | $316,192 |
Gross Profit | 8,794 | 6,196 | 1,979 | 310,830 |
EBITDA | -101,029 | -99,319 | -98,701 | 138,220 |
EBIT | -106,504 | -104,895 | -104,132 | 132,858 |
Net Income | -96,668 | -91,051 | -98,669 | 142,797 |
Net Change In Cash | 14,269 | 11,772 | 7,410 | 316,192 |
Free Cash Flow | -89,702 | -84,970 | -102,185 | 131,484 |
Cash | 230,203 | 292,763 | 287,848 | 435,895 |
Basic Shares | 82,410 | 82,312 | 81,698 | 82,702 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $377,709 | $60,920 | $51,844 | $24 |
Gross Profit | -59,672 | 38,343 | 35,403 | -103,155 |
EBITDA | -156,473 | -324,332 | -392,465 | -128,025 |
EBIT | -176,485 | -346,909 | -408,905 | -137,497 |
Net Income | -132,526 | -263,588 | -341,360 | -256,424 |
Net Change In Cash | 377,709 | 60,920 | 51,844 | 24 |
Cost of Revenue | 395,729 | |||
Free Cash Flow | -182,927 | -26,424 | -113,079 | -112,098 |
Cash | 435,895 | 232,767 | 965,647 | 162,171 |
Basic Shares | 77,151 | 70,015 | 64,227 | 46,733 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.17 |
2024-06-30 | -$1.11 |
2024-03-31 | -$1.21 |
2023-12-31 | $1.73 |
